forecast
Psilocybin may be approved for depression in 5-7 years
Two entities are running FDA-approved phase 2b multi-site trials of psilocybin for major depressive disorder or treatment-resistant depression, with promising early results, and approval could be forthcoming in roughly five to seven years or possibly sooner, depending on how clean the trials are and what auxiliary studies the FDA requires.
forecastpending
Speaker
Roland GriffithsEvidence Quote
“my guess is that approval for either treatment for resistant depression or major depressive disorder could be forthcoming in you know five to seven years maybe possibly sooner”
Created: 6/14/2026, 2:37:24 AM
Your notes
Loading notes...